Patient Feedback Spurs Expansion of ADDRESS-LC Trial: More Test Sites, Broader Enrollment

In July, Solve hosted a webinar featuring representatives of the ADDRESS-LC Trial, which was designed to assess the potential impact of the drug bezisterim on cognitive impairment/brain fog and fatigue […]
Watch! The ADDRESS-LC Trial Webinar

The ADDRESS-LC trial was designed to assess the potential impact of bezisterim on cognitive impairment/brain fog and fatigue in individuals with Long Covid and is currently recruiting people aged 18-64 […]